FDA Panel Narrowly Backs a First-of-a-Kind COVID-19 Antiviral Pill Made By Merck
FDA Panel Narrowly Backs a First-of-a-Kind COVID-19 Antiviral Pill Made By Merck
TIME
0 shares
2 views
You might like
Related news coverage
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
NYTimes.com
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the..
-
FDA panel backs first-of-a-kind COVID-19 pill from Merck
Chicago S-T
-
FDA panel narrowly recommends authorization of first antiviral to treat COVID-19
Delawareonline
-
Alert: FDA health panel endorses Merck COVID-19 pill, paving way for U.S. authorization of the first at-home drug for virus
SeattlePI.com
-
FDA Advisers Endorse Merck’s COVID Antiviral Drug In Narrow Vote
cbs4.com
Advertisement
More coverage
FDA Reviewing Merck's COVID Pill For Emergency Authorization
Newsy
Watch VideoAn experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one..
-
FDA advisors recommend authorization of Merck COVID antiviral pill molnupiravir
SeekingAlpha
-
FDA panel narrowly backs COVID-19 pill from Merck
Newsday
-
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
Business Insider
-
FDA advisory panel endorses Merck's COVID treatment pill in 13-10 vote
MarketWatch